Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Role of microRNAs in the anti-atherogenic effects of high-density lipoproteins

FY 2008-09

Summary
Atherosclerosis is a cardiovascular disease that is characterised by a chronic inflammatory response, the accumulation of white blood cells called macrophages, and the deposition of proteins that contain fatty material such as cholesterol and triglycerides into the blood vessel wall. In epidemiological studies, high plasma levels of high-density lipoproteins (HDLs), also known as good cholesterol, protect against the development of atherosclerosis. Indeed, work from the laboratory of Prof. Kerry-Anne Rye and Prof. Philip J. Barter has shown that one of the ways by which HDLs protect against the development of atherosclerosis is through their anti-inflammatory properties. The exact mechanisms are still unclear. The major aim of my fellowship research studies is to investigate the molecular and cellular basis of the cardioprotective and anti-inflammatory effects of HDLs. MicroRNAs have recently come into focus as powerful regulators of gene expression. They are a class of short, highly conserved RNA molecules. More than 500 human miRNAs have been identified so far and our early studies indicate that they contribute significantly to atherosclerosis. This research proposal asks whether HDLs protect against atherosclerosis by regulating the levels of specific miRNAs in the artery wall. This will be achieved by identifying miRNAs that are regulated by HDL in vitro and their respective targets in vivo. These studies may offer new therapeutic strategies to treat vascular diseases such as atherosclerosis.
Program
CIHR Fellowship
Location
Australia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
180848
Name
Tabet Fatiha
Country
Australia
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Role of microRNAs in the anti-atherogenic effects of high-density lipoproteins
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Atherosclerosis; Cholesterol Efflux; High-Density Lipoproteins; Micrornas And Inflammation; Molecular And Cellular Biology
Abstract
Atherosclerosis is a cardiovascular disease that is characterised by a chronic inflammatory response, the accumulation of white blood cells called macrophages, and the deposition of proteins that contain fatty material such as cholesterol and triglycerides into the blood vessel wall. In epidemiological studies, high plasma levels of high-density lipoproteins (HDLs), also known as good cholesterol, protect against the development of atherosclerosis. Indeed, work from the laboratory of Prof. Kerry-Anne Rye and Prof. Philip J. Barter has shown that one of the ways by which HDLs protect against the development of atherosclerosis is through their anti-inflammatory properties. The exact mechanisms are still unclear. The major aim of my fellowship research studies is to investigate the molecular and cellular basis of the cardioprotective and anti-inflammatory effects of HDLs. MicroRNAs have recently come into focus as powerful regulators of gene expression. They are a class of short, highly conserved RNA molecules. More than 500 human miRNAs have been identified so far and our early studies indicate that they contribute significantly to atherosclerosis. This research proposal asks whether HDLs protect against atherosclerosis by regulating the levels of specific miRNAs in the artery wall. This will be achieved by identifying miRNAs that are regulated by HDL in vitro and their respective targets in vivo. These studies may offer new therapeutic strategies to treat vascular diseases such as atherosclerosis.
Competitiondate
200902
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tabet, Fatiha
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~